MICHAEL A. ROGAWSKI is distinguished professor of neurology and pharmacology at the University of California, Davis School of Medicine, where he served as chair of the Department of Neurology until 2012. Prior to his appointment at UC Davis, he was senior investigator and chief of the Epilepsy Research Section at the National Institute of Neurological Disorders and Stroke. Dr. Rogawski’s research encompasses cellular neurophysiological studies of ion channels, studies on the actions of antiseizure medications in animal models, and clinical trials. His laboratory studies on AMPA receptors and neuroactive steroids have led to new treatment approaches for epilepsy and seizures. Dr. Rogawski has received the NIH Director’s Award, the ASPET Epilepsy Research Award, the American Academy of Neurology Neuroendocrine Research Award, and the UC Davis Chancellor’s Innovator of the Year award. He is a fellow of the American Neurological Association, the American Association for the Advancement of Science (cited for distinguished contributions in the fields of neuroscience, neuropharmacology and neurology, particularly applied to the treatment of epilepsy), and the National Academy of Inventors. Dr. Rogawski has served as an editor and editorial board members of many journals in neuroscience and pharmacology. He was awarded a B.A. (biophysics) from Amherst College, and M.D. and Ph.D. (pharmacology) from Yale University. He completed residency training in neurology at the Johns Hopkins Hospital.